Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Centrally, GLP-1 receptor agonists modulate brain regions controlling appetite and energy expenditure
A new paper published by pharmacist and PSM board member Dr
Summary Keywords endocrinology, growth hormone secretagogues, IGF-1 analogues, off-label use, peptide hormones, performance-enhancing drugs, sports doping Citation Dominikowski A, Rko Z, Olejarz M, Szczepanek-Parulska E, Domin R and Ruchaa M (2026) The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
PlexusDx offers tirzepatide injection at $289/mo (or $249/mo on the 6-month plan) or GLP-Squared dual-compound therapy at the same price for maximum synergistic benefits
FDA guidance for industry combined with initial FDA feedback specific to the pivotal Phase 3 program of avexitide for PBH suggest that reduction in hypoglycemia events could be an endpoint to support approval following positive results from a pivotal Phase 3 clinical trial
US$ 29.82
US$ 26.43
US$ 24.10
US$ 24.75
